BioMarin Pharmaceutical | BMRN - Crediti Commerciali

Prezzo Delle Azioni
53.30
Cambio Giornaliero
-0.51 -0.95%
Mensile
-2.72%
Annuale
-15.77%
Q2 Previsione
52.04




Crediti Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Bayer EUR 14.19B 720M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Moderna USD 184M 862M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 186.13M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
United Therapeutics USD 350.2M 52.5M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12